APA ציטוט

Reilly, S. M., Abu-Odeh, M., Ameka, M., DeLuca, J. H., Naber, M. C., Dadpey, B., . . . Saltiel, A. R. (2021). FGF21 is required for the metabolic benefits of IKKε/TBK1 inhibition. J Clin Invest.

Citação norma Chicago

Reilly, Shannon M., et al. "FGF21 Is Required for the Metabolic Benefits of IKKε/TBK1 Inhibition." J Clin Invest 2021.

ציטוט MLA

Reilly, Shannon M., et al. "FGF21 Is Required for the Metabolic Benefits of IKKε/TBK1 Inhibition." J Clin Invest 2021.